216 related articles for article (PubMed ID: 20638155)
21. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
22. [Prevention of catheter-related infection: usefulness and cost-effectiveness of antiseptic catheters in children].
Lenz AM; Vassallo JC; Moreno GE; Althabe M; Gómez S; Magliola R; Casimir L; Bologna R; Barretta J; Ruffa P
Arch Argent Pediatr; 2010 Jun; 108(3):209-15. PubMed ID: 20544135
[TBL] [Abstract][Full Text] [Related]
23. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
24. Central venous catheterization: a prospective, randomized, double-blind study.
Mer M; Duse AG; Galpin JS; Richards GA
Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746
[TBL] [Abstract][Full Text] [Related]
25. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care.
Khare MD; Bukhari SS; Swann A; Spiers P; McLaren I; Myers J
J Infect; 2007 Feb; 54(2):146-50. PubMed ID: 16678904
[TBL] [Abstract][Full Text] [Related]
26. Selection of the vascular catheter: can it minimise the risk of infection?
Bouza E; Guembe M; Muñoz P
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S22-5. PubMed ID: 21130605
[TBL] [Abstract][Full Text] [Related]
27. A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward.
Soothill JS; Bravery K; Ho A; Macqueen S; Collins J; Lock P
Am J Infect Control; 2009 Oct; 37(8):626-30. PubMed ID: 19616869
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
29. Infectious risk associated with arterial catheters compared with central venous catheters.
Lucet JC; Bouadma L; Zahar JR; Schwebel C; Geffroy A; Pease S; Herault MC; Haouache H; Adrie C; Thuong M; Français A; Garrouste-Orgeas M; Timsit JF
Crit Care Med; 2010 Apr; 38(4):1030-5. PubMed ID: 20154601
[TBL] [Abstract][Full Text] [Related]
30. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
[TBL] [Abstract][Full Text] [Related]
31. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis.
Casey AL; Mermel LA; Nightingale P; Elliott TS
Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192
[TBL] [Abstract][Full Text] [Related]
33. A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection.
Sannoh S; Clones B; Munoz J; Montecalvo M; Parvez B
Am J Infect Control; 2010 Aug; 38(6):424-9. PubMed ID: 20137829
[TBL] [Abstract][Full Text] [Related]
34. Preventing catheter-related bloodstream infections: an executive summary of the APIC elimination guide.
Rebmann T; Murphy CL
Am J Infect Control; 2010 Dec; 38(10):846-8. PubMed ID: 20971529
[TBL] [Abstract][Full Text] [Related]
35. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
Walder B; Pittet D; Tramèr MR
Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
[TBL] [Abstract][Full Text] [Related]
36. Prevention of central venous catheter-related infections: what works other than impregnated or coated catheters?
Mermel LA
J Hosp Infect; 2007 Jun; 65 Suppl 2():30-3. PubMed ID: 17540238
[TBL] [Abstract][Full Text] [Related]
37. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected.
Zingg W; Sax H; Inan C; Cartier V; Diby M; Clergue F; Pittet D; Walder B
J Hosp Infect; 2009 Sep; 73(1):41-6. PubMed ID: 19646788
[TBL] [Abstract][Full Text] [Related]
38. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?
McConnell SA; Gubbins PO; Anaissie EJ
Clin Infect Dis; 2003 Jul; 37(1):65-72. PubMed ID: 12830410
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection.
Jaffer Y; Selby NM; Taal MW; Fluck RJ; McIntyre CW
Am J Kidney Dis; 2008 Feb; 51(2):233-41. PubMed ID: 18215701
[TBL] [Abstract][Full Text] [Related]
40. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
